Background Primary prevention strategies for cardiovascular disease (CVD) conventionally rely on 10-year risk estimates of ...

Background and aims Hypertrophic cardiomyopathy (HCM) has various aetiologies, including genetic conditions like Fabry disease (FD), a lysosomal storage disorder. FD prevalence in high-risk HCM ...

Background Training in complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) has frequently been reserved for established operators (consultants ...

Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ongoing controversy regarding optimal anti-thrombotic therapy post-MVr. This ...

Background Visual assessment of coronary CT angiography (CCTA) is time-consuming, influenced by reader experience and prone to interobserver variability. This study evaluated a novel algorithm for ...

Background Current guidelines recommend transcatheter aortic valve implantation (TAVI) for patients with aortic stenosis and porcelain aorta (PA). Neurological outcomes of patients with PA undergoing ...

Introduction ST-elevation myocardial infarction (STEMI) is one of the most prevalent presentations in young patients. It is essential to emphasise that each minute of delay in providing medical care ...

Introduction Atherosclerotic Cardiovascular Disease (ASCVD) remains a leading cause of global cardiovascular mortality, responsible for 80% of related deaths. Lowering low-density lipoprotein ...

Introduction Heart attack, a worldwide phenomenon, remains one of the leading causes of mortality among adults. In Malaysia, it accounts for 17.0% out of 109,155 medically confirmed deaths. This ...

3 Department of Hematology, School of Medical Sciences, Universiti Sains Malaysia, Malaysia Introduction AL amyloidosis may develop in patients with multiple myeloma (MM) or may progress from ...